"Dr. Gregory Pamel is a New York City LASIK and vision correction surgery specialist with offices on the Upper East Side of Manhattan and Astoria. He is an attending surgeon at Northwell- Manhattan Eye, Ear and Throat Hospital and he is medical director of the Manhattan Surgery Center affiliated with Mount Sinai Hospital. He is also a clinical professor of ophthalmology at NYU School of Medicine. Dr. Pamel has invested in the most advanced state-of-the-art equipment to assist him in providing his patients the most accurate measurements and diagnoses related to their eyes."

During the past decade, Pamel Vision & Laser Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Pamel Vision & Laser Group" are "Cataract" (2 trials), "Astigmatism" (1 trials), "Ectasia" (1 trials), "Keratoconus" (1 trials) and "Keratoconus and Ectasia" (1 trials). Many other conditions were trialed in "Pamel Vision & Laser Group" in a lesser frequency.

Most popular intervention types in "Pamel Vision & Laser Group" are "Device" (5 trials) and "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Riboflavin" (3 trials), "VEGA UV-A Illumination System" (2 trials), "TECNIS Toric Models ZCT450, ZCT525 or ZCT600" (1 trials), "The VEGA UV-A Illumination System" (1 trials) and "non-toric intraocular lens" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pamel Vision & Laser Group" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Pamel Vision & Laser Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Pamel Vision & Laser Group, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Pamel Vision & Laser Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".